Singapore markets close in 1 hour 20 minutes
Straits Times Index
2,936.99-36.55(-1.23%)Nikkei
28,966.01-1,202.26(-3.99%)Hang Seng
29,062.65-1,011.52(-3.36%)
Translate Bio, Inc. (TBIO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.26-0.27 (-1.20%)
At close: 4:00PM EST
| Previous close | 22.53 |
| Open | 22.52 |
| Bid | 0.00 x 1400 |
| Ask | 0.00 x 800 |
| Day's range | 22.14 - 23.27 |
| 52-week range | 6.80 - 34.64 |
| Volume | 815,439 |
| Avg. volume | 1,301,541 |
| Market cap | 1.654B |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.01 |
| Earnings date | 25 Feb 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 32.25 |
- Zacks
The Zacks Analyst Blog Highlights: INO, NVAX, TBIO and VXRT
The Zacks Analyst Blog Highlights: INO, NVAX, TBIO and VXRT
- Motley Fool
3 mRNA Coronavirus Vaccine Stocks to Check Out That Aren't Pfizer, BioNTech, or Moderna
Messenger RNA (mRNA) coronavirus vaccine candidates now appear to be batting two for two. Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) announced great interim efficacy results for their experimental mRNA COVID-19 vaccine last week. Are there other biotech stocks with mRNA vaccine programs that could also be winners?
- Zacks
Sanofi's mRNA Vaccine for Coronavirus to Enter Clinical Stage
Sanofi (SNY) and Translate Bio select coronavirus vaccine candidate MRT5500 for clinical development, based on its promising pre-clinical data. A clinical study is anticipated by this year-end.
© 2021 Verizon Media. All rights reserved.
